Sun Phrama stocks jump 5% after clarifications
22-January-2019
Drug major Sun Phrama's shares gained over 5 per cent during Tuesday's morning trade session after clarifications by the company on various issues including its dealing with Suraksha Realty.
At 10.48 a.m, its stocks traded at Rs 419.05, up Rs 20.70 or 5.20 per cent from its previous close of Rs 398.35 on Monday.
The company in a regulatory filing said that the its distribution related to India Domestic Formulations Business shall be transitioned from Aditya Medisales Ltd., the current distributor, to a wholly owned subsidiary of Sun Pharma.
"This change will be made effective by Q1FY20, post receipt of all requisite regulatory approvals," the statement said.
This transaction was expected to be concluded in FY19, said the company.
The company also clarified that "neither any loans nor guarantees have been given to Suraksha Realty".
"The company states unequivocally that it does not have any financial transactions with Suraksha Realty."-IANS
First Indian Space Tourist Talks Dreams and Inspiration Before Blue Origin Flight
Former MLA Rathod Bapu Rao Switches from BJP to Congress in Telangana
Zerodha Co-Founder Nikhil Kamath Launches 'WTFund' to Support Young Entrepreneurs
Firing At Salman Khan’s Mumbai Residence: Delhi Police Launch Probe
upGrad Records 55,000 Job Placements in FY24, Boosting Careers in Tech and Marketing